marcusevans russia conferences

3rd Launching New Pharmaceuticals in Russia and CIS

Perspectives of drugs regulation and registration in the frame of EEU single market

16-18 Mar 2016
Moscow, Russian Federation

Conference Workshop

Workshop Title: Strategy and tactics of pre-clinical trials according to GLP standards
• Implementation strategy of GLP in the research laboratory. • Organizing pre-clinical trials in accordance with the GLP: Learning from original drug safety research. • Preparation of the research center for compliance assessment with GLP standards
Workshop Moderator: Maria Zaytseva
Company: Head of QA Department FSSI, The Institute of toxicology FMBA RF, PhD, Leading Researcher

Why You Should Attend

3rd Launching New Pharmaceuticals in Russia and CIS

This exclusive 3rd annual marcus evans forum will look at latest legislative initiatives and development trends of the pharmaceutical industry, which is currently going through significant changes and moving towards sustainable development within the Eurasian Economic Union. The correct interpretation of rules and principles of a single EEU space is highly important for pharmaceutical market players. This event is a unique networking opportunity for business representatives and regulators to discuss key regulatory and development challenges of the industry. The forum will pay a special attention to functioning of harmonized EEU drugs market, perspectives of national markets regulation and regulatory aspects of clinical trials. Along with this we will be discussing specifications of drugs registration, quality control of medicines and medical products, implementation of GMP standards as well as opportunities for localization of manufacturing facilities.


Key Topics

  • Discuss the first results of working in the harmonized Eurasian Economic Union space
  • Consider strategies of further pharmaceutical industry development in the Eurasian Economic Union
  • Evaluate prospects of national markets regulation within the EEU
  • Improve approaches to the drug registration
  • Review recent legislative initiatives of drugs’ market regulation
  • Previous Attendees Include

    Abbott Laboratories, Abdi Ibrahim Global Pharm, Accell Clinical Research, Almirall S.A., Arterium, Association of the Russian Pharmaceutical Manufacturers (ARPM), Astellas Pharma Europe B.V MRO, Baxter, Bayer, Bayer Healthcare Pharmaceuticals, Besins Healthcare Rus LLC, Biocad, Biogen Idec, Bionika Media, Bionorica, Biorasi LLC, Brend Pharm, Center of Expertise and Clinical Trials, CJSC KPMG, CSL Behring AG, Develco Pharma GmbH, Elanco Animal Health, Eli Lilly, EurAsEC Committee, Ever Neyro Pharma, FARMAPLANT, Ferrer Internacional S.A, Formula- FR, Frensenius Medical Care Kazakhstan LLC, Fresenius Kabi Deutschland, Gedeon Richter Plc, Generium, Glaxosmithkline,
    Gorodissky & Partners, Jadran Galenski Laboratorij, Johnson&Johnson, Laboratoire Innotech International, Meabco A/S, Medisorb, Merck Serono, Nearmedic Plus Ltd,
    NTPharma, I.M. Sechenov First Moscow State Medical University, Nuvo Research GmbH, Parma Clinical, Pharm-Holding, Pharmindustry Kazakhstan Association, Pik-Pharma, Polpharma - Akrikhin, Probiotech, Reckitt Benckiser Healthcare, Roche Latvia, RUS Biopharm LLC, Solvay Interox Ltd, Stada, Standards of Pharmaceutical Market, Takeda, Teva, Teva Russia, Worwag Pharma GmbH & Co KG, Zentiva a Sanofi Company

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Partners

    Practical Insights From

    Elena Popova
    Director Regulatory Affairs and Healthcare Policy
    The Association of International Pharmaceutical Manufacturers

    Dmitry Rumyancev
    General Director
    ROZLEX PHARM LLC, Member of working group on establishing common medicines regulation approaches in the Eurosian Economic Union

    Krasilnikova Elena
    Deputy Head of EurAsEC Institute. Head of the Centre for Studies and Analysis of Population, Demography and Healthcare Issues
    EurAsEC Institute

    Liliya Titova
    Executive Director
    Union of Professional Pharmaceutical Organizations

    Maria Zaytseva
    Head of QA Department FSSI
    The Institute of toxicology FMBA RF, PhD, Leading Researcher

    Elena Sycheva
    Head of Regulatory Affairs department
    Bayer Pharma

    Click Here For Full Agenda

    Voice of Our Customers
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Veronika Sapronova

    101 Finsbury Pavement
    EC2A 1ER

    +44 (0)20 3002 3435
    Fax: +44 (0)20 3002 3016